Your browser doesn't support javascript.
loading
The beneficial effect of Escalated-R-CHOP-21 for the treatment of diffuse large B-cell lymphoma in elderly male patients: A propensity-matched cohort study.
He, Hai-Xia; Gao, Yan; Bai, Bing; Wang, Xiao-Xiao; Li, Ji-Bin; Huang, Cheng; Mao, Jia-Ying; Ping, Li-Qin; Rong, Qi-Xiang; He, Yan-Xia; Huang, He; Cai, Qing-Qing; Li, Zhi-Ming; Jiang, Wen-Qi; Huang, Hui-Qiang.
Afiliación
  • He HX; State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Gao Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Bai B; State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wang XX; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Li JB; State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang C; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Mao JY; State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Ping LQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Rong QX; Department of Clinical Research, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • He YX; State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang H; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Cai QQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Li ZM; State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Jiang WQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang HQ; State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Cancer Med ; 10(21): 7650-7664, 2021 11.
Article en En | MEDLINE | ID: mdl-34581023
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Rituximab Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Rituximab Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos